Ratings by UBS (Dan Leonard)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/27/2026 | Natera | NTRA | Maintain | Buy (Buy) |
|
Details | ||
| 2/26/2026 | Agilent | A | Maintain | Buy (Buy) |
|
Details | ||
| 2/25/2026 | Repligen | RGEN | Maintain | Buy (Buy) |
|
Details | ||
| 2/25/2026 | Charles River Labs | CRL | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/20/2026 | 10X Genomics | TXG | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/12/2026 | Avantor Inc. | AVTR | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/10/2026 | Waters Corp. | WAT | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/9/2026 | Qiagen NV | QGEN | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/6/2026 | IQVIA Holdings | IQV | Maintain | Buy (Buy) |
|
Details | ||
| 2/6/2026 | Illumina | ILMN | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/5/2026 | Bio-Techne Corp. | TECH | Maintain | Buy (Buy) |
|
Details | ||
| 1/21/2026 | Qiagen NV | QGEN | Maintain | Neutral (Neutral) |
|
Details | ||
| 12/19/2025 | Agilent | A | Maintain | Buy (Buy) |
|
Details | ||
| 11/25/2025 | Agilent | A | Maintain | Buy (Buy) |
|
Details | ||
| 11/24/2025 | Exact Sciences | EXAS | Maintain | Neutral (Neutral) |
|
Details | ||
| 11/20/2025 | Exact Sciences | EXAS | Maintain | Neutral (Neutral) |
|
Details | ||
| 11/6/2025 | Bio-Techne Corp. | TECH | Maintain | Buy (Buy) |
|
Details | ||
| 11/4/2025 | Bruker | BRKR | Maintain | Neutral (Neutral) |
|
Details | ||
| 10/30/2025 | Guardant Health | GH | Maintain | Buy (Buy) |
|
Details | ||
| 10/30/2025 | Guardant Health | GH | Maintain | Buy (Buy) |
|
Details | ||
| 10/24/2025 | West Pharmaceutical | WST | Maintain | Buy (Buy) |
|
Details | ||
| 10/23/2025 | Thermo Fisher Scientific | TMO | Maintain | Neutral (Neutral) |
|
Details | ||
| 10/7/2025 | Agilent | A | Upgrade | Buy (Neutral) |
141.61 (155.59) |
9.87% | Details | |
| 9/23/2025 | Guardant Health | GH | Maintain | Buy (Buy) |
|
Details | ||
| 8/27/2025 | Bio-Rad Labs | BIO | Maintain | Buy (Buy) |
|
Details | ||
| 8/19/2025 | Natera | NTRA | Maintain | Buy (Buy) |
|
Details | ||
| 8/7/2025 | Certara Inc. | CERT | Maintain | Buy (Buy) |
|
Details | ||
| 8/4/2025 | Avantor Inc. | AVTR | Maintain | Neutral (Neutral) |
|
Details | ||
| 8/1/2025 | Bio-Rad Labs | BIO | Maintain | Buy (Buy) |
|
Details | ||
| 7/29/2025 | Medpace | MEDP | Downgrade | Sell (Neutral) |
447.49 (611.97) |
36.76% | Details | |
| 7/25/2025 | West Pharmaceutical | WST | Maintain | Buy (Buy) |
|
Details | ||
| 7/24/2025 | Thermo Fisher Scientific | TMO | Maintain | Neutral (Neutral) |
|
Details | ||
| 7/22/2025 | Medpace | MEDP | Maintain | Neutral (Neutral) |
|
Details | ||
| 7/15/2025 | Waters Corp. | WAT | Maintain | Neutral (Neutral) |
|
Details | ||
| 7/9/2025 | Thermo Fisher | TMO | Downgrade | Neutral (Buy) |
91.09 (620.00) |
580.65% | Details | |
| 6/4/2025 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 5/27/2025 | Waters Corp. | WAT | Maintain | Neutral (Neutral) |
|
Details | ||
| 5/9/2025 | Bio-Techne Corp. | TECH | Maintain | Buy (Buy) |
|
Details | ||
| 5/9/2025 | Natera | NTRA | Maintain | Buy (Buy) |
|
Details | ||
| 5/8/2025 | Charles River Labs | CRL | Maintain | Neutral (Neutral) |
|
Details | ||
| 5/8/2025 | Bruker | BRKR | Maintain | Neutral (Neutral) |
|
Details | ||
| 5/2/2025 | Bio-Rad Labs | BIO | Maintain | Buy (Buy) |
|
Details | ||
| 5/1/2025 | Revvity Inc | RVTY | Upgrade | Buy (Neutral) |
93.43 (119.58) |
27.99% | Details | |
| 3/19/2025 | West Pharmaceutical | WST | Maintain | Buy (Buy) |
|
Details | ||
| 3/14/2025 | Mettler-Toledo | MTD | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/28/2025 | Natera | NTRA | Maintain | Buy (Buy) |
|
Details | ||
| 2/21/2025 | Guardant Health | GH | Maintain | Buy (Buy) |
|
Details | ||
| 2/14/2025 | Bio-Rad Labs | BIO | Maintain | Buy (Buy) |
|
Details | ||
| 1/17/2025 | Charles River Labs | CRL | Downgrade | Neutral (Buy) |
173.91 (293.09) |
68.53% | Details | |
| 1/17/2025 | Avantor Inc. | AVTR | Downgrade | Neutral (Buy) |
21.76 (14.21) |
-34.7% | Details | |
| 1/10/2025 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2024 | Bruker | BRKR | New Coverage | Neutral (N/A) |
61.45 (58.56) |
-4.7% | Details | |
| 11/19/2024 | Natera | NTRA | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2024 | Bio-Rad Labs | BIO | Maintain | Buy (N/A) |
|
Details | ||
| 9/27/2024 | Medpace | MEDP | Downgrade | Neutral (Buy) |
320.58 (447.49) |
39.59% | Details | |
| 9/27/2024 | Certara Inc. | CERT | Upgrade | Buy (Neutral) |
10.46 (8.70) |
-16.83% | Details | |
| 8/9/2024 | Natera | NTRA | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2024 | Certara Inc. | CERT | Maintain | Neutral (N/A) |
|
Details | ||
| 8/5/2024 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 8/2/2024 | Bio-Rad Labs | BIO | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2024 | Bio-Rad Labs | BIO | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2024 | Revvity Inc | RVTY | Maintain | Neutral (N/A) |
|
Details | ||
| 3/1/2024 | Certara Inc. | CERT | Maintain | Neutral (N/A) |
|
Details | ||
| 2/29/2024 | Natera | NTRA | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2024 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 2/16/2024 | Bio-Rad Labs | BIO | Maintain | Buy (N/A) |
|
Details | ||
| 12/7/2023 | Bio-Rad Labs | BIO | New Coverage | Buy (N/A) |
305.78 (365.29) |
19.46% | Details | |
| 12/7/2023 | Certara Inc. | CERT | New Coverage | Neutral (N/A) |
14.83 (10.46) |
-29.47% | Details | |
| 12/7/2023 | Fulgent Genetics | FLGT | New Coverage | Neutral (N/A) |
25.95 (18.53) |
-28.59% | Details | |
| 12/7/2023 | Bio-Techne Corp. | TECH | New Coverage | Buy (N/A) |
64.38 (72.35) |
12.38% | Details |
